GnRH analogues and dienogest for second line treatment of endometriosis-associated pain: a systematic review, meta-analysis, and network meta-analysis
review
OA: closed
CC0
⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This systematic review, meta-analysis, and network meta-analysis compared GnRH analogues and dienogest as second-line treatments for endometriosis-associated pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Conscious pain mapping by laparoscopy in women with chronic pelvic pain via openalex
- Deep Dyspareunia, Superficial Dyspareunia, and Infertility Concerns Among Women With Endometriosis: A Cross-Sectional Study via openalex
- Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis via openalex
- Dienogest in long-term treatment of endometriosis via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex
- Dienogest Versus Leuprolide Acetate for Recurrent Pelvic Pain Following Laparoscopic Treatment of Endometriosis via openalex
- Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial via openalex
- Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis via openalex
- Efficacy of Dienogest on Pelvic Pain and Dyspareunia: Comprehensive Meta-Analysis and Systematic Review via openalex
- Endometriosis via openalex
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment via openalex
- Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- Long-term treatment of endometriosis with dienogest for up to five years via openalex
- Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- The Burden of Endometriosis on Women’s Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing via openalex
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial via openalex
- Use of dienogest in endometriosis: a narrative literature review and expert commentary via openalex
- W6809509812 via openalex
- W2008203144 via openalex
- W2144625636 via openalex
- W2970684805 via openalex
- W3203416324 via openalex
- W4214754424 via openalex
- W4234160457 via openalex
- W4287640102 via openalex
- W4307085869 via openalex
- W4403682469 via openalex
- W6669621150 via openalex
- W6681100027 via openalex
- W6767567325 via openalex
- W6791250557 via openalex
- W1946443235 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-24T00:31:26.415442+00:00
- unpaywall
- last seen: 2026-06-04T02:00:05.705006+00:00
License: CC0
· commercial use OK